Kara Q&A: How to “support” a friend or family member that’s affected with Charcot-MarieTooth.

by | Dec 15, 2014 | 2 comments

Kara PictureMy name is Courtney Hollett, Fundraising Coordinator at the Hereditary Neuropathy Foundation. This time of year I count my blessing daily and wanted to share with you a Q&A session I had with a new supporter of HNF. Kara, like myself has many family members affected with CMT and I reached out to her to share her thoughts and advice about how to “support” a friend or family member that’s affected with Charcot-MarieTooth.


COURTNEY: Tell us about yourself Where you live? Favorite hobbies?

KARA: I grew up in Crystal Lake, Illinois and lived in Chicago for 5 years before moving to New York City. I currently live in Manhattan. I love to travel internationally and spend time with my family in the Chicago area–my Mom, Dad, two sisters, two brothers-in-law, and my favorite little munchkins — my niece Kenzie (4 1/2 years old) and nephew Jack (2 years old). I also enjoy photography, animals, and the great food, wine, and culture of NYC, including Broadway musicals and plays

COURTNEY: How are you affected by CMT?

KARA: My Grandmother, Mother, and sister have CMT.

COURTNEY: Why are you fundraising for CMT?

KARA: I’m fundraising to raise awareness and support CMT research efforts.

It is no surprise to me that CMT is often referred to as “the biggest disease you’ve never heard of.” Growing up, I always thought my sister had just inherited my Mom’s feet, muscular build, and coordination. My family had never heard of CMT. For years, my Mom and sister frequently sought treatment from doctors and podiatrists. It wasn’t until about 10 years ago that a podiatrist on staff told my sister about CMT during an office visit to an orthopedist for a knee injury. The information available on the disease at that time was limited. Even now, my family has seen several doctors who have never heard of the disease.

Hopefully raising awareness will help doctors diagnose the disease early, help to educate those impacted regarding different treatment options, ways to manage the disease on a daily basis (including understanding those medications that are contraindicated for those with CMT), as well as provide hope that current research will lead to a treatment for CMT.

COURTNEY: How has CMT changed your life?

KARA: CMT has significantly impacted my entire family.

Most recently, my sister underwent several major foot/ankle surgeries. It has been very difficult, both physically and emotionally, yet my mom and my sister continue to amaze me. My sister works each day to improve her strength and recover with two young children at home. Of course, my Mom and the rest of my family are right by her side.

After connecting with HNF and learning more information about CMT, I am more determined than ever to raise CMT awareness and contribute to research efforts to find a treatment or cure.

COURTNEY: If you care for someone with CMT do you have any information for others?

KARA: Be supportive and informed. Try to learn about the disease and don’t be afraid to talk about it. While it may be a difficult and emotional subject to discuss initially, if you care for someone with CMT, I believe that being open about it helps show your support and helps you understand and be sensitive to your loved ones’ day-to-day challenges.

For years, I have felt both upset that my mom and sister have CMT – and completely helpless. Becoming involved in fundraising efforts and helping to raise awareness has been the most effective and rewarding way for me to show my love and support. It has helped me to feel empowered and feel that I am doing something to make a difference in their lives and in the lives of others impacted by CMT.

COURTNEY: What’s a favorite quote that you think of often?

KARA: “Our lives are not determined by what happens to us but how we react to what happens, not by what life brings us but the attitude we bring to life.” —Wade Boggs


Learn more on this topic

Related Blog Posts

Double Your Donation

Corporate matching gift programs are charitable giving programs setup by corporations in which the company matches donations made by employees to eligible nonprofit organizations. For example, if a donor works for Bank of America and donates $100 to the Hereditary Neuropathy Foundation, Bank of America will double the donation by also writing a check for $100.

Taking Matters Into Your Own Hands

Do you have a rare form of CMT?

We were contacted recently from a patient with CMT2D who was looking for advice on how to make a difference. Our recommendations for all people with an ultra-rare form of CMT who want to get involved:

Now GRIN is Accessible in 141 Different Languages!

Now GRIN is Accessible in 141 Different Languages!

The Global Registry for Inherited Neuropathies (GRIN) has implemented Google Translate. Why did we choose Google? Because Google is leading the way in teaching computers how to interpret meaning, avoiding the traditional method of decoding language.

Accelerating Patient Access to Investigational Drugs in 2015

Accelerating Patient Access to Investigational Drugs in 2015

Currently the FDA is working to update the process for physicians applying for accelerated patient access to investigational drugs, while the drug or biological product is being tested in clinical trials. This will also be important for the CMT community as clinical trials for this disease are being launched.

Do You Have Charcot-Marie-Tooth Type 4 (CMT4)? – We Need Your Help

Autosomal recessive demyelinating CMT4 patients present with earlyonset and slowly progressing symptoms. These include progressive distally accentuated weakness and atrophy of muscles in the lower limbs. In addition, patients may have weakness and atrophy of hands, sensory loss and pes cavus (high-arched feet), and walking difficulties. Further information on CMT4 can be found at Orphanet.

Hot Off the Press – Potential Treatment for CMT1A

Two recent publications from Pharnext describe a novel synergistic combination of 3 drugs (baclofen, naltrexone and sorbitol) and its effect on CMT1A both in the lab and in a phase II clinical trial. These 3 drugs already approved but for unrelated conditions, are combined at new optimal lower doses and under a new formulation. This novel potential therapeutic is called PXT-3003.

Support CMT Therapeutic Alliance

HNF has entered into a joint venture – the CMT Therapeutic Alliance – with a unique non profit organization (BioPontis Alliance for Rare Diseases) that brings professional drug discovery capabilities to translate our research results into potential treatments.

Scientific Advisory Board Meeting

Scientific Advisory Board Meeting

On the 7th of November we convened our scientific advisory board meeting at the HNF offices in NY. We have written a detailed review that has been published and captures all of the discussion and make this freely available to the scientific community.

Join the conversation

Leave a Comment


  1. Denise

    Kara, your are so correct, informing the public about this disease is one of the first steps in finding a cure for the disease and allowing those that have it the feeling of not being alone. I am inspired by your efforts and care. Keep up the great work.
    Warren and Denise

  2. Georgie

    Thank you for sending this Kara. I am so proud of you, not only as you raise awareness for CMT, but also being the biggest supporter for your family. You’re inspiring me to do the same and would love to help raise awareness in any way I can. You’re amazing!

    Your friend,


Submit a Comment

Your email address will not be published. Required fields are marked *


Join for notifications on events, campaigns, & news